REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Bristol-Myers Squibb Co. (NY: BMY)
46.40 USD  +2.34 (+5.31%)
Official Closing Price  /  Updated: 4:15 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Blog posts about Bristol-Myers Squibb Co.
 
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Stock Futures Flat on China amid M&A News. Stocks to Watch: AMLN, AAPL, CELL, BMY, FB, IM, LNCR, MU, WYNN
July 02, 2012
New York, July 2nd (TradersHuddle.com) – Stock futures were pointing to a flat opening after big Friday’s rally, as disappointing manufacturing data in China was offsetting a flurry of M&A news.... Read More
from TradersHuddle.com
Stock Futures Flat amid Low EU Summit Expectations. Stocks to Watch: AAPL, BMY, DV, FB, GIS, LEN, MON, ORLY
June 27, 2012
New York, June 27th (TradersHuddle.com) – Stock futures were pointing to a flat open as investors continued to have low expectations over the possible outcomes of a key EU summit schedule to start... Read More
from TradersHuddle.com
Pharma-Karma: $1 Billion Fines No Biggie for Illegally Promoting Off-Label Drug Use
June 18, 2012
category AZN , ABT , PFE , and 3 more.
from YCharts
Healthcare Stocks: What Happens if Obamacare is Overturned
June 14, 2012
With the Supreme Court ruling on President Barack Obama's healthcare reform law just three weeks away, investors in healthcare stocks need to be prepared. While some are confident the Supreme Court... Read More
category Affordable care act , insurance , healthcare stocks , and 6 more.
from Money Morning
(BMY) Bristol-Myers Squibb Company Presents Positive Data
June 06, 2012
Bristol-Myers Squibb Company (BMY) recently presented encouraging data from a late-stage study... Visit StockBlogHub to view complete post. Read More
category Mylan Inc/ , Dr/ Reddy's Laboratories Limited , Sanofi/Aventis , and 13 more.
from Stock Blog Hub
Growth & Income Stock: Mead Johnson Nutrition Company
June 05, 2012
Estimates have been rising for Mead Johnson Nutrition Company (MJN) after the company delivered its 6th consecutive positive earnings surprise. It is a Zacks #2 Rank (Buy) stock. Based on consensus... Read More
category MJN , Stocks , External Research , and 2 more.
from DailyMarkets.com
Mylan Launches Bonviva Generic
May 25, 2012
Mylan Inc. (NYSE:MYL) recently announced that its UK and Italian subsidiaries have launched its generic version of Roche Holding’s (RHHBY) osteoporosis drug, Bonviva (ibandronic acid), 150 mg. Bonviva... Read More
category RHHBY , SNY , Stocks , and 4 more.
from DailyMarkets.com
More Generic Launches For Mylan
May 24, 2012
Mylan Pharmaceuticals Inc., a subsidiary of generic pharma major Mylan Inc. (NYSE:MYL), recently announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its... Read More
category SNY , Stocks , MYL , and 3 more.
from DailyMarkets.com
FDA Nod For Merck Drug Label Update
May 24, 2012
Merck (NYSE:MRK) recently announced that the U.S. Food and Drug Administration (FDA) approved a label update for its HIV therapy, Isentress. The FDA has allowed Merck to update Isentress’ label so that... Read More
category MRK , Stocks , External Research , and 3 more.
from DailyMarkets.com
Gilead Drug Up For European Review
May 24, 2012
Recently, Gilead Sciences, Inc. (NASDAQ:GILD) announced that its marketing application seeking approval for its candidate cobicistat in the EU has been validated by the European Medicines Agency (EMA).... Read More
category jnj , Stocks , External Research , and 4 more.
from DailyMarkets.com
Generic Launches Continue At Mylan
May 21, 2012
Mylan Pharmaceuticals Inc., a subsidiary of generic player, Mylan Inc. (NYSE:MYL), recently announced that it has received final approval from the U.S. Food & Drug Administration (FDA) to launch... Read More
category RDY , SNY , TEVA , and 5 more.
from DailyMarkets.com
RDY Adds To Generic Portfolio
May 21, 2012
Dr. Reddy’s Laboratories (NYSE:RDY) has been busy launching generics and the recent U.S. launch of a generic version of Novatis AG’s (NYSE:NVS) over-the-counter (OTC) drug, Prevacid, was the second one... Read More
category RDY , NVS , Stocks , and 3 more.
from DailyMarkets.com
Dr. Reddy’s Launches Plavix’ Generic
May 18, 2012
Dr. Reddy’s Laboratories (NYSE:RDY) recently announced the U.S. launch of a generic version of Bristol-Myers Squibb & Co.’s (NYSE:BMY) blood thinner, Plavix. The U.S. Food and Drug Administration (FDA)... Read More
category RDY , TEVA , Stocks , and 3 more.
from DailyMarkets.com
New Analyst Coverage: ACOR, BMY, CODE, MU, SNDK
May 18, 2012
New York, May 18th (TradersHuddle.com) - These are the research analyst new ratings before the market open. Acorda Therapeutics ( NASDAQ:ACOR ) was initiated with a Sell at Goldman Sachs. Br. Read More... Read More
from TradersHuddle.com
Merck KGaA’s Erbitux Faces Hurdle
May 17, 2012
Merck KGaA (MKGAF) recently reported disappointing interim data from a late-stage study (PETACC-8) on Erbitux (cetuximab), which is being evaluated as an adjuvant treatment of stage III colon cancer.... Read More
category AZN , RHHBY , External Research , and 8 more.
from DailyMarkets.com
Manufacturing Facility Cleared At BMY
May 16, 2012
Bristol-Myers Squibb Company (NYSE:BMY) received some encouraging news when the U.S. Food and Drug Administration (FDA) cleared a biologics manufacturing facility of the company for producing its... Read More
category SNY , Stocks , External Research , and 3 more.
from DailyMarkets.com
BMY Inks Deal With Chinese University
May 15, 2012
Recently, Bristol-Myers Squibb Company (NYSE:BMY) inked a multi-year deal with the research oriented Chinese university Tsinghua, founded in 1911. Per the terms of the deal, the Chinese University’s... Read More
category SCR , Stocks , External Research , and 2 more.
from DailyMarkets.com
Good News For Gilead
May 14, 2012
Gilead Sciences (NASDAQ:GILD) received some encouraging news recently when an advisory panel of the U.S. Food and Drug Administration (FDA) recommended the approval of the company’s HIV combination... Read More
category Stocks , External Research , Contributor , and 3 more.
from DailyMarkets.com
Simcere Misses On All Fronts
May 10, 2012
Simcere Pharmaceutical Group’s (NYSE:SCR) first quarter 2012 earnings of 8 cents per American Depositary Share (ADS) were in-line with the year-ago earnings but short of the Zacks Consensus Estimate by... Read More
category SCR , MRK , Stocks , and 3 more.
from DailyMarkets.com
Biotech Takeovers: Who’s Next On The Block?
May 04, 2012
While most sectors see their constituents moved by more benign news such as earnings reports, dividend increases/decreases, share repurchases, insider buying/selling and scores of other typical... Read More
from TradersHuddle.com
Investing in Biotech Stocks: The Buyout Binge Continues
April 27, 2012
The biotechnology buyout deals just keep coming, meaning those investing in biotech stocks have scored some juicy profits - with more on the way. Watson Pharmaceuticals (NYSE: WPI ) announced Wednesday... Read More
category biotech stocks to watch , Top News , biotech stocks list , and 11 more.
from Money Morning
Stock Market News Briefs: Bristol-Myers Squibb Company, Colgate-Palmolive Company, Dow Chemical Company, Kellogg Company, Pepsico, United Parcel Service, Exxon Mobil Corporation
April 27, 2012
    Exxon Mobil Corporation (NYSE:XOM) posted first quarter earnings per share of $2.00, missing the Zacks Consensus Estimate of $2.11     PepsiCo, Inc. (NYSE:PEP) reported first quarter earnings per... Read More
category PEP , ups , K , and 7 more.
from DailyMarkets.com
Celgene Misses, Reaffirms
April 26, 2012
Celgene Corporation’s (NASDAQ:CELG) first quarter 2012 earnings (excluding special items but including stock-based compensation expense) of 96 cents per share beat the year-ago earnings by 35%. Higher... Read More
category CELG , Stocks , MYL , and 4 more.
from DailyMarkets.com
Earnings Beat At Bristol-Myers
April 26, 2012
Bristol-Myers Squibb Company’s (NYSE:BMY) first quarter 2012 earnings (excluding special items) of 64 cents per share beat the Zacks Consensus Estimate of 61 cents. First quarter earnings increased 10%... Read More
category AZN , SNY , Stocks , and 4 more.
from DailyMarkets.com
Earnings Preview: Celgene
April 24, 2012
Celgene Corporation (NASDAQ:CELG) is set to unveil its first quarter 2012 results on April 26, 2012 before the start of trading. The Zacks Consensus Estimate for the first quarter is $1.02... Read More
category CELG , Stocks , MYL , and 4 more.
from DailyMarkets.com
Earnings Preview: Bristol-Myers
April 23, 2012
Biopharmaceutical giant Bristol-Myers Squibb Company (NYSE:BMY) is all set to report its first quarter 2012 results before the start of trading on April 26, 2012. The Zacks Consensus Estimate for the... Read More
category AZN , SNY , Stocks , and 4 more.
from DailyMarkets.com
Vertex Reports Positive Data On Incivek
April 20, 2012
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) recently reported positive data from a mid-stage study (PROVE 2) on Incivek (telaprevir), when dosed in combination with pegylated-interferon and ribavirin for... Read More
category Stocks , External Research , Contributor , and 3 more.
from DailyMarkets.com
Why our portfolio is John Deere green
April 18, 2012
Deere is trading at close to ten times estimated 2012 earnings which is a modest multiple vs. that of the S&P. Read More
category DE , James Roberts , Manager Commentary , and 2 more.
from Smarter Investing
Amylin Completes BLA Submission
April 09, 2012
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) recently completed the submission of its rolling Biologics License Application (BLA) for metreleptin to the US Food and Drug Administration (FDA). Amylin is... Read More
category AMLN , Stocks , External Research , and 2 more.
from DailyMarkets.com
Amylin Shoots Up On Takeover Rumors
March 29, 2012
Amylin Pharmaceutical (NASDAQ:AMLN) shares shot up 54.45% on rumors regarding a take-over bid by Bristol-Myers Squibb (NYSE:BMY). According to Bloomberg, which cited unnamed sources, Bristol-Myers had... Read More
category AMLN , Stocks , External Research , and 3 more.
from DailyMarkets.com
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here